Skip to main content
Article
Quantification and characterization of granulocyte macrophage colony-stimulating factor activated human peripheral blood mononuclear cells by fluorine-19 cellular MRI in an immunocompromised mouse model
Diagnostic and Interventional Imaging
  • C Fink
  • M Smith
  • O C Sehl
  • J M Gaudet
  • T C Meagher
  • N A Sheikh
  • Jimmy Dikeakos
  • Michael Rieder, University of Western Ontario
  • P J Foster
  • G A Dekaban
Document Type
Article
Publication Date
9-1-2020
URL with Digital Object Identifier
https://doi.org/10.1016/j.diii.2020.02.004
Disciplines
Abstract

PURPOSE: The purpose of this study was to test fluorine-19 (19F) cellular magnetic resonance (MRI) as a non-invasive imaging modality to track therapeutic cell migration as a surrogate marker of immunotherapeutic effectiveness.

MATERIALS AND METHODS: Human peripheral blood mononuclear cell- (PBMC)-derived antigen presenting cell (APC) were labeled with a 19F-perfluorocarbon (PFC) and/or activated with granulocyte macrophage colony-stimulating factor (GM-CSF). Viability, phenotype and cell lineage characterization preceded 19F cellular MRI of PFC

RESULTS: A high proportion of PBMC incorporated PFC without affecting viability, phenotype or cell lineage composition. PFC

CONCLUSION: 19F cellular MRI is a non-invasive imaging technique capable of detecting and quantifying in vivo cell migration in conjunction with an established APC-based immunotherapy model. 19F cellular MRI can function as a surrogate marker for assessing and improving upon the therapeutic benefit that this immunotherapy provides.

Notes

This article was first published in Diagnostic and Interventional Imaging at https://doi.org/10.1016/j.diii.2020.02.004.

Creative Commons License
Creative Commons Attribution-Noncommercial-No Derivative Works 4.0
Citation Information
C Fink, M Smith, O C Sehl, J M Gaudet, et al.. "Quantification and characterization of granulocyte macrophage colony-stimulating factor activated human peripheral blood mononuclear cells by fluorine-19 cellular MRI in an immunocompromised mouse model" Diagnostic and Interventional Imaging Vol. 101 Iss. 9 (2020) p. 577 - 588
Available at: http://works.bepress.com/michael-rieder/14/